SSB and cancer: All 174 PCa sera were analyzed for antibodies to the autoantigens SSA52, SSA60, and SSB which are commonly used biomarkers in systemic rheumatic autoimmune diseases, and none of the cancer sera showed reactions above the cut-off OD, whereas SLE and PSS sera showed the expected percentage of positive reactors (data not shown).